Coagulopathy is a severe and frequent complication in critically ill patients, for which the pathogenesis and presentation may be variable depending on the underlying disease. Based on the dominant clinical phenotype, the current review differentiates between hemorrhagic coagulopathies, characterized by a hypocoagulable and hyperfibrinolysis state, and thrombotic coagulopathies with a systemic prothrombotic and antifibrinolytic phenotype. We discuss the differences in pathogenesis and treatment of the common coagulopathies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00134-023-06980-6 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!